David A. Neel

(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ

Michael R. Jirousek, James R. Gillig, Cécile Gonzalez et al. · Journal of Medicinal Chemistry · 1996 · 338 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists

David A. Neel, Matthew L. Brown, Peter A. Lander et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 54 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Asymmetric synthesis of 4-[(t-butoxycarbonyl)amino]-pyrazolidin-3-one: Precursor to bicyclic pyrazolidinone antibacterials

Richard E. Holmes, David A. Neel · Tetrahedron Letters · 1990 · 38 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Orally absorbable cephalosporin antibiotics. 1. Structure-activity relationships of benzothienyl- and naphthylglycine derivatives of 7-aminodeacetoxycephalosporanic acid

S. KUKOLJA, Susan E. Draheim, Janice L. Pfeil et al. · Journal of Medicinal Chemistry · 1985 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors.

Stanley R. Howell, Michael A. Shirley, Timothy A. Grese et al. · PubMed · 2001 · 36 citations

Medicine, Medicinal Chemistry, Pharmacology +14